According to OncoCyte 's latest financial reports the company's current EPS (TTM) is -$14.26. In 2022 the company made an earnings per share (EPS) of -$18.44 an increase over its 2021 EPS that were of -$19.72.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$13.92 | -24.52% |
2022 | -$18.44 | -6.48% |
2021 | -$19.72 | 54.35% |
2020 | -$12.78 | 6.98% |
2019 | -$11.94 | 2.38% |
2018 | -$11.67 | -34.38% |
2017 | -$17.78 | 48.84% |
2016 | -$11.94 | -35.18% |
2015 | -$18.43 |